These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25773416)

  • 61. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
    Hamzavi I; Jain H; McLean D; Shapiro J; Zeng H; Lui H
    Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis].
    Vañó-Galván S; Gárate MT; Fleta-Asín B; Hidalgo A; Fernández-Guarino M; Bermejo T; Jaén P
    Actas Dermosifiliogr; 2012 Mar; 103(2):127-37. PubMed ID: 22036021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study.
    Asawanonda P; Charoenlap M; Korkij W
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):133-6. PubMed ID: 16719866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Cystine in the treatment of vitiligo].
    Orecchia G; Perfetti L
    G Ital Dermatol Venereol; 1989; 124(11-12):529-31. PubMed ID: 2638646
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients.
    Percivalle S; Piccino R; Caccialanza M; Forti S
    G Ital Dermatol Venereol; 2008 Feb; 143(1):9-14. PubMed ID: 18833047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Vitiligo--loss of cutaneous pigmentation].
    Sitek JC
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2370-2. PubMed ID: 16998548
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms.
    Sheth VM; Currimbhoy SD; Feetham HJ; Graves MS; Chan J; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2012 Aug; 67(2):318-20. PubMed ID: 22794808
    [No Abstract]   [Full Text] [Related]  

  • 70. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
    Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effectiveness of home-based phototherapy for vitiligo: A systematic review of randomised controlled trials.
    Ashraf AZ; Azurdia RM; Cohen SN
    Photodermatol Photoimmunol Photomed; 2022 Sep; 38(5):409-417. PubMed ID: 34967477
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Noninvasive cutaneous blood flow as a response predictor for visible light therapy on segmental vitiligo: a prospective pilot study.
    Yu WT; Yu HS; Wu CS; Lee CH; Cheng YC; Lin WT; Chen GS; Lan CC
    Br J Dermatol; 2011 Apr; 164(4):759-64. PubMed ID: 21087230
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phototherapy in pediatric patients: choosing the appropriate treatment option.
    Pugashetti R; Koo J
    Semin Cutan Med Surg; 2010 Jun; 29(2):115-20. PubMed ID: 20579600
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 76. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
    Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy.
    Hallaji Z; Ghiasi M; Eisazadeh A; Damavandi MR
    Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):115-9. PubMed ID: 22548391
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients.
    Adauwiyah J; Suraiya HH
    Med J Malaysia; 2010 Dec; 65(4):297-9. PubMed ID: 21901949
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment.
    Lee DY; Kim CR; Park JH; Lee JH
    Int J Dermatol; 2011 Aug; 50(8):925-7. PubMed ID: 21781062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
    Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.